Robert Menendez Jr. actually said...

PBMs benefit significantly from high list prices and have no incentive to choose lower-priced drugs to drive down patient costs.

Pharmacy benefit managers are key players, or should be, in alleviating patients' financial burden at the pharmacy counter.

This level of concentration gives these PBMs market power over data, drug coverage, and contracting--80 percent.

High list prices hurt patients who must pay these prices. If list prices were lower, out-of-pocket payments based on list prices would be lo...